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Lumbar spinal stenosis: methods of treatment  
with emphasis on epidural steroid injections
Abstract 
Background and Purpose: The aim of the study was to compare two 
techniques of steroid application into epidural space to patients with lumbar 
spinal stenosis (LSS), a chronic degenerative spine disorder.
Patients and Methods: Sixty LSS patients have been distributed into 
2 groups: “BLIND” (n=30, interlaminar epidural steroid injection without 
RTG control) and “RTG” (n=30, transforaminal epidural injection with 
RTG control). All patients have received 80 mg of triamcinolon (Kenalog) 
into epidural space on L4/L5 level, together with 0,5% lidocain (patients in 
RTG group 3 ml and those in BLIND group 10 ml) in 3 week intervals. 
They were asked to describe the pain using visual analogue scales (VAS) at 
the beginning of treatment (VAS-0), after the first (VAS-1), the second 
(VAS-2) and the third epidural injection (VAS-3). The differences between 
groups were shown using t-test (age) and c2-test (gender). Medians of VAS 
scores were statistically described using non parametrial methods. P<0.05 
was considered as a statistically significant.
Results:  There is no statistical difference among patients regarding to 
age (P=0.93), gender (P=0.12) and VAS-0 score before the first injection 
(P=0.27). There is a statistically significant reduction of pain in relation to 
VAS-0 in both groups (P<0.001). Both groups do not statistically differ 
when it comes to their effectiveness in regards to VAS scores .
Conclusions: We  did not find any statistical difference in postinterven-
tional VAS scores among two groups of patients. Choice of technique depends 
on the experience of the anesthesiologist, as well as on the local technical 
possibilities (availibility of RTG devices).
INTRODUCTION
Lumbar spinal stenosis (LSS) is a chronic, degenerative spine disorder and most common reason for pain and disability among people 
older than 60 years of age (1).
LSS can be a result of degenerative changes that result in neural 
ischemia and neurogenic claudication, a typical syimptom that is de-
scribed as a pain in the gluteus with irradiation into both legs, usually 
reaches knees; weekness, parasthesia. The pain is most often felt while 
walking, standing for longer periods and walking downhill. All these 
changes significantly decrease the quality of life (2).
LSS is a result of degenerative spinal cascade, hence the stenosis has 
effects on central canal and nerve root canals as well (Fig.1). It is believed 
that neurogenic claudication is a result of structural narrowing of central 
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spinal canal, which impeds the venous return, thus caus-
ing venous hypertension and arterial ischemia of cauda 
equina (3).
The pain is decreased when leaning forward and over 
a supporting object (pushing a shopping trolley or walk-
ing with the aid of walkers). Since more areas are involved, 
patients suffering from LSS can have unilateral, bilateral, 
monoradicular or poliradicular symptoms (4). 
Pathogenesis
LSS pathogenesis depends on multiple factors. There 
are vascular, biochemical and biomechanical factors that 
contribute to the signs and symptoms of  LSS (3). 
Diagnosis
Patients̀ history of illness states pain in glutei with ir-
radiation into both legs, usually above and at the level of 
knees, weekness, parasthesia that increases while standing 
and walking. 
The patients are at ease when flexing the spine. Com-
puted tomography (CT) scans and magnetic resonance 
imaging (MRI) confirm the diagnosis. 
Because of the involvement of more areas, patients 
with LSS can have unilateral, bilateral, monoradicular or 
poliradicular symptoms (5). 




• Walking aids (walkers)
•  Drugs (Paracetamol, nonsteroidal antiinflamatory 
drugs, low doses of opioids)
• Physical therapy and exercises
Interventional
• Epidural steroid injections
• Surgery
Conservative treatment is used early in the course of 
illness and among patients with mild to moderate symp-
toms. Multidisciplinary treatment is necessary and should 
involve physical therapy, wellness, smoking cessation and 
weight loss, if needed (6,7).
Pharmacological treatment
The first choice are nonsteroidal antiinflamatory drugs 
(NSAID). Opioid analgetics undoubtedly decrease pain, 
but are still controversal as a treatment of spinal stenosis 
(8). There is not sufficient evidence that joint use of gaba-
pentin and physical therapy decreases pain and improves 
walking distance (9). Moreover, there is not enough evi-
dence for usage of muscle relaxants, prostaglandin and 
calcitonin. 
Surgical treatments are used after all other options 
have failed and in patients that experience moderate to 
severe symptoms (10, 11).
When it comes to interventional methods, epidural 
steroid injections (ESI) are one of the most common used 
methods in treatment of chronic pain in lowerback and 
legs (6, 12, 13).
There are 3 most often used approaches when injecting 
steroids.
• interlaminar (blind method)
• caudal 
• Ttransforaminal (controlled with RTG)
Transforaminal approach implies the use of RTG in 
order to reach the nerve root. That is why a smaller amount 
of drug can be used and that makes it superior to the two 
therapy approaches. However, the chances for nerve dam-
age with this approach are significantly higher (6, 14).
The effectiveness of injecting steroids into epidural 
space of patients with LSS is wellknown. However, there 
are not so many papers that compare the difference be-
tween both techniques when it comes to pain relief. The 
aim of this retrospective study is to show the difference 
between transforaminal and interlaminar epidural ste-
roids injections and theire efect on pain reduction. 
PATIENT AND METHODS
Sixty patients with LSS have been distributed into 2 
groups: “BLIND”(n=30, interlaminar epidural steroid 
injection without RTG control) and “RTG” (n=30, trans-
foraminal epidural injection with RTG control).Patients 
in both groups have received 80 mg of triamcinolon 
(Kenalog) into epidural space on L4/L5 level, together 
with 0,5% lidocain (patients in RTG group 3 ml and 
those in BLIND group10 ml). Patients from both groups 
received epidural steroid injections in 3 week intervals. 
They were asked to describe the pain using visual ana-
logue scales (VAS) at the beginning of treatment (VAS-0), 
Figure: 1.
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after the first (VAS-1), the second (VAS-2) and the third 
epidural injection (VAS-3).The differences between 
groups were shown usingt-test (age) i c2-test (gender). 
Medians of VAS scores were statistically described using 
non parametrial methods. P<0.05 was considered as a 
statistically significant.
RESULTS
There is no statistical difference among patients when 
it comes to age (P=0.93), gender (P=0.12) and VAS-0 
score before the first injection(P=0.27). There is a statisti-
cally significant reduction of pain in relation to VAS-0 in 
both groups (P<0.001). Both groups, “BLIND” and 
“RTG”, do not statistically differ when it comes to their 
effectiveness in regards to VAS scores (Table 1).
TAbLe 1
VAS scores after the epidural steroides injec-
tions (Mann-Whitney U test).
VAS








VAS-0 8 (7, 9) 7.5 (7, 9) .266
VAS-1 6 (5, 6) 5 (4, 6) .072
VAS-2 5 (4, 6) 4 (4, 5.25) .098
VAS-3 4 (3, 5) 4 (3, 4) .085
CONCLUSION
We did not find any statistical difference in postinter-
ventional VAS scores among patients with LSS who re-
ceived interlaminal (»BLIND») and transforaminal 
(“RTG”) epidural steroid injections.  Even though this 
research was conducted with a small number of partici-
pants, we conclude that the choice of technique depends 
on the experience of the anesthesiologist, as well as on the 
local technical possibilities (availibility of RTG devices). 
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